Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

First Page		Document Content
Date: 2015-04-01 04:38:50 Multiple sclerosis Medicine Immunology Clinical medicine Autoimmune diseases Neurological disorders Neurology Management of multiple sclerosis Glatiramer acetate Immunosuppressants McDonald criteria Diagnostic criteria for MS		Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 240,99 KB Share Document on Facebook

	Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 DocID: 1rmwo - View Document
	Society Commits Over $21 Million for 78 New MS Research Projects The National Multiple Sclerosis Society has committed over $21 million to support an expected 78 new MS research projects. These are part of a comprehensiv DocID: 1qQNE - View Document
	MSIF 07 pp1-28 • English v2.qxd DocID: 1qz0Q - View Document
	Multiple Sclerosis (MS) Self-Management Plan  Follow your medical provider’s directions regarding medicines.  Do not stop medicines without first checking with your medical or mental health provider.  Do not r DocID: 1qqkO - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qn6Z - View Document